Niranjan Thiruvur, Murea Mariana, Susztak Katalin
Department of Medicine/Nephrology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Nephron Exp Nephrol. 2009;111(4):e73-9. doi: 10.1159/000209207. Epub 2009 Mar 17.
Podocytes play a key role in the maintenance of the glomerular filtration barrier. Depletion or dysregulative mechanisms of podocytes can lead to the development of glomerulosclerosis. Signaling pathways that control these processes in podocytes are not fully understood. Recent studies from our and other laboratories found that genes that belong to the Notch pathway are regulated in patients and in animal models of renal disease. Genetic studies performed on mice with conditional expression of active Notch1 protein showed massive albuminuria, glomerulosclerosis, and ultimately renal failure and death of the animals. gamma-Secretase inhibitors and genetic deletion of Notch transcriptional binding partner (Rbpj) protected animals from nephrotic syndrome. Further studies are needed to define whether the activation of Notch pathway in podocytes represents a common pathomechanism in glomerular injury, and its potential to be a therapeutic target for the treatment of chronic kidney disease.
足细胞在维持肾小球滤过屏障中起关键作用。足细胞的耗竭或调节异常机制可导致肾小球硬化的发展。控制足细胞中这些过程的信号通路尚未完全了解。我们实验室和其他实验室最近的研究发现,在肾病患者和动物模型中,属于Notch通路的基因受到调控。对具有活性Notch1蛋白条件性表达的小鼠进行的基因研究显示,动物出现大量蛋白尿、肾小球硬化,最终肾衰竭并死亡。γ-分泌酶抑制剂和Notch转录结合伴侣(Rbpj)的基因缺失可保护动物免受肾病综合征的影响。需要进一步研究来确定足细胞中Notch通路的激活是否代表肾小球损伤的常见发病机制,以及其作为慢性肾脏病治疗靶点的潜力。